Balgrist Ecosystem – an Innovative Network for Musculosceletal Medicine

The Balgrist ecosystem is a network of cooperating organizations that are dedicated to providing the best medical care for patients with musculoskeletal problems. Through unparalleled combination of state-of-the-art infrastructures and technologies, the network creates the foundation for translational research, teaching and medical innovations.

Das Balgrist-Ökosystem ist ein Netzwerk, bestehend aus Klinik, Forschung, Innovation, Lehre und Start-ups, und schafft die Grundlage für die translationale Forschung und muskuloskelettale Medizin von heute und morgen.

"The partnership with Balgrist University Hospital offers us the opportunity to jointly develop new solutions for surgical techniques and training methods, including in the areas of augmented reality, robotics, and artificial intelligence. Our aim in this interdisciplinary collaboration is to continuously improve patient care through research."

– Professor Christian Wolfrum, ETH Vice President for Research

The Swiss Balgrist Association – the Governing Body of the Balgrist University Hospital since 1909

Association

Looking back on a history of over 112 years, the founders were dedicated to supporting physically disabled children. The Swiss Balgrist Association remains a charitable organization, a non-profit organization run according to economic principles, private institution. The Association's purpose is to promote the health of people with conditions affecting the musculoskeletal system. Working in cooperation with University of Zurich, ETH, and partner organizations, the Association also encourages research and teaching relating to the musculoskeletal system. Together with its research partners, Balgrist has medical excellence in the area of the musculoskeletal system at its disposal, which guarantees the University Hospital a top position internationally.

Website

Schweizerischer Verein Balgrist

Der Schweizerische Verein Balgrist bezweckt die Förderung der Gesundheit von Personen mit Leiden am Bewegungsapparat – gemeinnützig und nach betriebswirtschaftlichen Grundsätzen. In Kooperation mit der Universität Zürich, der ETH Zürich und weiteren Partnerorganisationen fördert er zudem die Lehre und Forschung am Bewegungsapparat.

The New Trial Center for Modern Research Management

Clinical Trial Unit Balgrist

The Clinical Trial Unit Balgrist, created in September 2024, is a further development of the already established Unit for Clinical and Applied Research (UCAR) and now offers its services to all Balgrist clinican scientists and researchers. As an integral part of Balgrist University Hospital, it supports researchers in administration and creates harmonized, efficient processes, enabling us to meet the demands of today's research community and the regulatory requirements for increasingly complex scientific initiatives.

Website

Clinical Trial Unit Balgrist

Die neu gegründete Clinical Trial Unit Balgrist ist eine Weiterentwicklung des bereits etablierten UCAR (Unit for Clinical and Applied Research) und unterstützt die Forschenden in der Administration, schafft harmonisierte Prozesse und trägt somit zur Effizienzsteigerung bei.

Connecting Minds, Advancing Musculoskeletal Care

Research and Innovation Node

Balgrist's Research & Innovation Node envisions building bridges both within and beyond Balgrist's translational cosmos. We foster a dynamic ecosystem by harmonizing research and innovation networks. The Node empowers the entire translational process and nurtures mutually beneficial partnerships. By facilitating collaborations with clinical, academic, industry, and political stakeholders, the Node strengthens visibility and aids in securing funding and sponsorships for research, innovation, and training initiatives.

Further Information:
Dr. Flora Vajda
Head of Research and Innovation Node
E-Mail

Website

Research & Innovation Node

Der Research & Innovation Node agiert am Forschungsstandort Balgrist als wichtige Schnittstelle zwischen den verschiedenen Anspruchsgruppen. Er fördert die Translation und pflegt enge Beziehungen zu Partnern aus Klinik, Forschung, Wirtschaft und Politik.

Balgrist Beteiligungs AG – from Lab to Market

Innovation Management

Balgrist Beteiligungs AG supports researchers and start-ups within the Balgrist Ecosystem. It supports scientific research and developments in orthopedic medicine that are based directly on the needs of patients. Research is organized in start-ups for the development of new products. Balgrist Beteiligungs AG not only offers financial support, but also enables collaboration with relevant partners and provides access to business know-how. It cooperates closely with the Unitectra.

Website

Balgrist Beteiligungs AG

Die Balgrist Beteiligungs AG begleitet die Forscherinnen und Forscher und deren Start-ups. Sie unterstützt die wissenschaftliche Forschung und Entwicklung in der orthopädischen Medizin, die sich unmittelbar an den Bedürfnissen der Patientinnen und Patienten orientiert.

“Our top priority is to actively support research and start-ups. This ensures that groundbreaking discoveries swiftly translate into benefits for patients. We advocate for increased industry involvement, particularly in the high-risk early stages for start-ups. By fostering supportive conditions, we can maximize the number of marketable innovations reaching patients, preventing promising ideas from languishing unrealized."

– Robert Zingg, Vice President of the Balgrist Association, Chairman of the Board of Directors of Balgrist Beteiligungs AG

ZuriMED is a Swiss start-up that spun off from Balgrist Biomechanics in 2015.
The company strives to revolutionize soft tissue repair in orthopedic sports medicine by developing breakthrough technologies and products. Their current focus lies in the augmentation of rotator cuff repair using their novel FiberLocker® System. 

Website

25Segments is a plattform for supporting early-stage innovation projects of researchers and physicians, focused on implant developments and research. 

Website

Emerging from a promising concept of spinal stabilization with tendon fi xations of spinal segments, Moving Spine aims to establish innovative treatment strategies, avoiding spinal fusions and keeping spinal segments moving. 

Website

X23D delivers a real-time AI platform for surgical guidance, decision making and error prevention. Their novel artificial intelligence software engines provide the basis for a reimagined surgical navigation product that is “Accurate whilst simple”.


Incremed develops mixed reality products for surgery, such as SonoEyes and HoloNavigation, using artificial intelligence to advance diagnostics and therapeutic interventions across various medical disciplines. 

Website


Augmedi's mission is to transform medical education by leveraging advanced AR technology and photorealistic 3D anatomical models. The company empowers medical students and professionals with a revolutionary AI-integrated learning platform for personalized experiences.

Website

Open Platforms for Musculoskeletal Research

Balgrist Campus

Since 2017, Balgrist Campus has been a Research Institution of National Importance by the federal government. The Swiss Federal government has invested more than 30 million Swiss Francs over the last eight years in three Swiss Centers hosted as platforms at the Balgrist Campus: Biobanking, Imaging and Movement Analysis. Balgrist Campus is thus part of a unique national platform for musculoskeletal research, development, and translation.
The Swiss Centers for Musculoskeletal Imaging SCMI, Musculoskeletal Biobanking SCMB, and Movement Analysis SCMA form three pillars of a highly specialized open access research infrastructure at Balgrist Campus, which specialize in conducting studies, particularly in the field of musculoskeletal medicine. The three platforms are available for use by national and international research groups, start-ups and industry and are happy to support with their infrastructure and expertise.

Website

Balgrist Campus

Seit 2017 ist der Balgrist Campus eine Forschungseinrichtung von nationaler Bedeutung. Das Zentrum für muskuloskelettale Forschung und Entwicklung erhielt vom Bund mehr als 30 Millionen Franken für die Infrastruktur und den Betrieb der neu zu errichtenden Open-Access- Forschungsplattformen: Swiss Center for Musculoskeletal Imaging (SCMI), Biobanking (SCMB) und Movement Analysis (SCMA). Der Balgrist Campus ist Teil einer einzigartigen nationalen Plattform für muskuloskelettale Forschung und Translation, und die drei Plattformen stehen nationalen und internationalen Forschungsgruppen, Start-ups und der Industrie zur Nutzung zur Verfügung.

Translational Center for Surgery

Operating Room X

The Operating Room X (OR-X) is an open-access center for surgical research and training. As a national research infrastructure, OR-X combines a highly realistic surgical environment with cutting-edge technology. At the heart of OR-X is a fully equipped operating room, designed for tomorrow's surgical research and training.
The 1,185 m2 OR-X core facility is located within Balgrist University Hospital. Visitors enter through a separate entrance, via a spectacular spiral staircase. The ultramodern OR-X enables the use of innovative technologies and ultimately transforms the standard of patient care. The lower floor houses the surgical infrastructure for research and training, where entire ex-vivo surgeries can be performed using human specimens. The rooms are equipped for all types of open, arthroscopic /endoscopic, computer-assisted, or robotic interventions. On the upper floor, there is a reception and welcome area, a waiting / recreation lounge, changing rooms with showers, as well as meeting and workspaces.

Website

Operating Room X

Der Operating Room X (OR-X) an der Universitätsklinik Balgrist ist ein internationales Zentrum für chirurgische Forschung und Ausbildung. Die Anlage bietet auf einer Fläche von 1185 m² eine einzigartige Kombination aus realistischer Operationsumgebung und modernster Technologie. Hier werden nicht nur Ex-vivo-Operationen an menschlichen Proben durchgeführt, sondern auch offene, arthroskopische, endoskopische und robotergestützte Eingriffe trainiert. Besucherinnen und Besucher des OR-X betreten die Einrichtung über eine spektakuläre Wendeltreppe und erleben eine Atmosphäre, die dazu einlädt, die chirurgische Forschung und Ausbildung von morgen zu gestalten.

“ As a university research institution, Balgrist University Hospital makes a valuable contribution to cutting-edge medicine in Zurich, which is highly regarded both nationally and internationally. The OR-X and the research groups at Balgrist are dedicated to mission of University Medicine Zurich (UMZH): Together we work on research for the medicine of the future.”

– Professor Beatrice Beck Schimmer, Vice President Medicine, University of Zurich